Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Adam Burdorf"'
Autor:
Scott W. Lundgren, DO, Brian D. Lowes, MD, PhD, Elizabeth Lyden, MS, Ronald Zolty, MD, PhD, Adam Burdorf, DO, MS, Marshall Hyden, MD, John Um, MD, Douglas A. Stoller, MD, PhD
Publikováno v:
Transplantation Direct, Vol 7, Iss 10, p e752 (2021)
Introduction. Although pulmonary function testing (PFT) is typically performed for heart transplant evaluation, the prognostic utility of PFTs after transplantation is unknown. We evaluated whether PFT parameters were correlated with outcomes followi
Externí odkaz:
https://doaj.org/article/09d51326738c40049d551c53b849607a
Publikováno v:
Oman Medical Journal, Vol 36, Iss 1, Pp e230-e230 (2021)
Spontaneous coronary artery dissection is a serious and underreported clinical entity strongly associated with fibromuscular dysplasia (FMD). The female predominance of FMD may predispose many women to coronary artery dissection or other similar vasc
Externí odkaz:
https://doaj.org/article/77137302a259404aa20122078cfb1143
Autor:
Vinay Thohan, Jacob Abraham, Adam Burdorf, Nasir Sulemanjee, Brian Jaski, Maya Guglin, Francis D. Pagani, Himabindu Vidula, David T. Majure, Rebecca Napier, Thomas J. Heywood, Rebecca Cogswell, Nicholas Dirckx, David J. Farrar, Stavros G. Drakos
Publikováno v:
Circulation: Heart Failure.
Background: Hemodynamic-guided management with a pulmonary artery pressure (PAP) sensor (CardioMEMS TM ) is effective in reducing heart failure hospitalization (HFH) in patients with chronic heart failure (HF). This study aims to determine the feasib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::af77becca47aa77518e45d0081d75498
https://doi.org/10.1161/circheartfailure.122.009960
https://doi.org/10.1161/circheartfailure.122.009960
Autor:
Theresa Diederich, Adam Burdorf, Bunny Pozehl, Stephanie Bowman, Kelly Ferguson, Kyana Holder, Windy Alonso, Douglas Stoller, Scott Lundgren
Publikováno v:
Heartlung : the journal of critical care. 57
Guideline-directed medical therapy (GDMT) reduces mortality and hospitalizations in adults with heart failure with reduced ejection fraction (HFrEF); however, few are receiving GDMT. National registries show as few as 1% of patients are receiving app
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69c06a330e4ff711c45b2db5b0c4cf0d
https://pubmed.ncbi.nlm.nih.gov/36088681
https://pubmed.ncbi.nlm.nih.gov/36088681
Publikováno v:
Heart, Lung and Circulation. 28:946-952
Pulmonary hypertension secondary to left heart disease (WHO Group 2) is a known risk factor in patients with heart failure. The favourable effect of left ventricular assist devices (LVAD) on pulmonary hypertension has been demonstrated before, althou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b595b9e7e54373253ba5d95f1c9b8c06
https://doi.org/10.1016/j.hlc.2018.04.299
https://doi.org/10.1016/j.hlc.2018.04.299
Autor:
Douglas Stoller, Brian D. Lowes, Elizabeth Lyden, John Y. Um, Scott Lundgren, Adam Burdorf, Ronald Zolty, Marshall Hyden
Publikováno v:
Transplantation Direct, Vol 7, Iss 10, p e752 (2021)
Transplantation Direct
Transplantation Direct
Supplemental Digital Content is available in the text.
Introduction. Although pulmonary function testing (PFT) is typically performed for heart transplant evaluation, the prognostic utility of PFTs after transplantation is unknown. We evaluated
Introduction. Although pulmonary function testing (PFT) is typically performed for heart transplant evaluation, the prognostic utility of PFTs after transplantation is unknown. We evaluated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::675861388f659dbe39a1bc85998103bf
https://doi.org/10.1097/txd.0000000000001177
https://doi.org/10.1097/txd.0000000000001177
Autor:
Ronald Zolty, Douglas Stoller, Stephanie Bowman, Theresa Diederich, Bunny Pozehl, Kyana Holder, Marshall Hyden, Scott Lundgren, Adam Burdorf, Brian D. Lowes, Kelly Ferguson
Publikováno v:
Journal of Cardiac Failure. 26:S131-S132
Background While heart failure (HF) is a leading cause of mortality and readmissions, only a small percentage of patients are optimized on guideline-directed medical therapy (GDMT). We developed a multidisciplinary HF clinic to optimize medications,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7cdbaf1015bf07255532410a6d72c450
https://doi.org/10.1016/j.cardfail.2020.09.381
https://doi.org/10.1016/j.cardfail.2020.09.381
Autor:
Douglas Stoller, Adam Burdorf, Ronald Zolty, Kajari Dhar, Brian D. Lowes, Arif Albulushi, Marshall Hyden
Publikováno v:
The Journal of Heart and Lung Transplantation. 39:S507-S508
Purpose Endothelin-1 (ET-1), a potent vasoconstrictor, is elevated in heart failure as well as in pulmonary arterial hypertension (PAH). To our knowledge little is known about ET-1 level in exercise induced pulmonary hypertension when compared to gro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8623dd3bb7a00d77c1d5aabd7ccde6c8
https://doi.org/10.1016/j.healun.2020.01.117
https://doi.org/10.1016/j.healun.2020.01.117
Autor:
Douglas Stoller, Elizabeth Lyden, Brian D. Lowes, Marshall Hyden, John Y. Um, Ronald Zolty, Scott Lundgren, Adam Burdorf
Publikováno v:
The Journal of Heart and Lung Transplantation. 39:S280
Purpose Lung disease is common in the advanced heart failure population. While pulmonary function testing (PFT) is typically performed as part of a heart transplant evaluation, little is known regarding the prognostic utility of PFTs for outcomes aft
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bd55062d80a6fc26ef734d9136cb9279
https://doi.org/10.1016/j.healun.2020.01.616
https://doi.org/10.1016/j.healun.2020.01.616
Autor:
Arif Albulushi, Daniel Zolty, Kajari Dhar, Adam Burdorf, Douglas Stoller, Marshall Hyden, Brian Lowes, Ronald Zolty
Publikováno v:
Journal of the American College of Cardiology. 75:2103
Cyclic guanosine monophosphate (cGMP) plays an important role as pulmonary vasodilator and currently there are targeted therapy to stimulate cGMP in the management of patients with pulmonary hypertension. It is known that patients with pulmonary hype
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::38dce8ff2e1411a7f1a53ca9288266c2
https://doi.org/10.1016/s0735-1097(20)32730-3
https://doi.org/10.1016/s0735-1097(20)32730-3